We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+10.55%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$31.2B
AUM Growth
+$3.46B
(+13%)
Cap. Flow
+$507M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
27.05%
Holding
8,536
New
1,430
Increased
3,215
Reduced
2,538
Closed
961
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$71.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$66.5M |
| 3 |
First Solar
FSLR
|
+$29.3M |
| 4 |
ARK Innovation ETF
ARKK
|
+$14.8M |
| 5 |
Strategy Inc
MSTR
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$41.7M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.3M |
| 3 |
NVIDIA
NVDA
|
+$21M |
| 4 |
TSMC
TSM
|
+$18.7M |
| 5 |
Palo Alto Networks
PANW
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.66% |
| 2 | Consumer Discretionary | 1.61% |
| 3 | Financials | 0.73% |
| 4 | Communication Services | 0.72% |
| 5 | Healthcare | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
3826
DELISTED
Revance Therapeutics, Inc.
RVNC
| $222K | ﹤0.01% |
8,777
-19,016
| -68% | -$592K |
|
3827
PUT
Talos Energy
TALO
$2.62B
| $222K | ﹤0.01% |
16,000
+11,700
| +272% | +$158K |
|
3828
PUT
Ionis Pharmaceuticals
IONS
$9.2B
| $222K | ﹤0.01% |
5,400
+2,800
| +108% | +$108K |
|
3829
CALL
POET Technologies
POET
$1.48B
| $221K | ﹤0.01% |
50,100
-12,300
| -20% | -$53K |
|
3830
Blackrock
BLK
$177B
| $220K | ﹤0.01% |
319
+157
| +97% | +$105K |
|
3831
Weibo
WB
$1.93B
| $220K | ﹤0.01% |
16,767
-13,862
| -45% | -$220K |
|
|
AMED
3832
PUT
DELISTED
Amedisys
AMED
| $219K | ﹤0.01% |
+2,400
| New | +$197K |
|
|
RENT
3833
CALL
Rent the Runway
RENT
$121M
| $219K | ﹤0.01% |
5,540
+2,465
| +80% | +$121K |
|
3834
PUT
Kontoor Brands
KTB
$4.16B
| $219K | ﹤0.01% |
5,200
+4,500
| +643% | +$193K |
|
3835
CALL
Kymera Therapeutics
KYMR
$8.95B
| $218K | ﹤0.01% |
9,500
-55,400
| -85% | -$1.59M |
|
3836
CALL
Gevo
GEVO
$408M
| $218K | ﹤0.01% |
143,500
-6,600
| -4% | -$8.53K |
|
3837
CALL
Planet Labs
PL
$8.49B
| $217K | ﹤0.01% |
67,500
-61,100
| -48% | -$242K |
|
3838
PUT
ARS Pharmaceuticals
SPRY
$584M
| $217K | ﹤0.01% |
32,400
+19,100
| +144% | +$127K |
|
|
NSTG
3839
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $217K | ﹤0.01% |
53,600
+51,200
| +2,133% | +$378K |
|
3840
CALL
Ultragenyx Pharmaceutical
RARE
$2.66B
| $217K | ﹤0.01% |
+4,700
| New | +$218K |
|
3841
CorMedix
CRMD
$576M
| $217K | ﹤0.01% |
54,665
+43,001
| +369% | +$213K |
|
3842
PUT
Penske Automotive Group
PAG
$14.3B
| $217K | ﹤0.01% |
1,300
-14,700
| -92% | -$2.13M |
|
3843
CEL-SCI Corp
CVM
$26.4M
| $216K | ﹤0.01% |
2,992
-3,285
| -52% | -$239K |
|
3844
PUT
Dentsply Sirona
XRAY
$2.34B
| $216K | ﹤0.01% |
5,400
+100
| +2% | +$3.98K |
|
3845
PUT
RB Global
RBA
$16.6B
| $216K | ﹤0.01% |
3,600
-161,100
| -98% | -$9.08M |
|
3846
Trinity Industries
TRN
$2.28B
| $216K | ﹤0.01% |
+8,399
| New | +$192K |
|
3847
CALL
Kayne Anderson Energy Infrastructure Fund
KYN
$2.48B
| $216K | ﹤0.01% |
26,500
-7,300
| -22% | -$60.1K |
|
3848
CALL
Community Health Systems
CYH
$400M
| $216K | ﹤0.01% |
49,000
-17,700
| -27% | -$75.4K |
|
3849
CALL
Aspen Aerogels
ASPN
$508M
| $215K | ﹤0.01% |
27,300
+25,600
| +1,506% | +$178K |
|
3850
PUT
STAG Industrial
STAG
$7.1B
| $215K | ﹤0.01% |
+6,000
| New | +$207K |
|
Similar funds
SCP
RIM
Group One Trading's Q2 2023 Portfolio in Review
As of Q2 2023, Group One Trading held 8,536 positions worth $31.2B, up 13% from $27.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Group One Trading's Q2 2023 filing shows 1,430 new, 3,215 increased, 2,538 reduced and 961 closed positions. Its largest new stake was Meta Platforms (Facebook): 269,312 shares worth $77.3M. The largest sale was UnitedHealth, an estimated $41.7M.
By sector, the portfolio is most concentrated in Technology at 1.7% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Financials.
- Group One Trading's largest Q2 2023 buy was Meta Platforms (Facebook): 269,312 shares worth $77.3M.
- Group One Trading added most to Tesla in Q2 2023, an estimated $71.4M increase.
- Group One Trading's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $41.7M.
- Group One Trading fully exited NVIDIA in Q2 2023, selling an estimated $21M.
- Group One Trading's ten largest holdings make up 27% of its $31.2B portfolio in Q2 2023.
- Group One Trading opened 1,430 new positions and closed 961 in Q2 2023.
- Group One Trading's portfolio value rose 13% quarter-over-quarter to $31.2B.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.